Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2012 Financial Results



  Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter
  and Full Year 2012 Financial Results

Business Wire

HAYWARD, Calif. -- January 17, 2013

Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the Company will
release its fourth quarter and full year 2012 financial results on Monday,
February 25, 2013, after the close of the U.S. financial markets. The Company
will host a conference call and live webcast with the investment community at
4:30 p.m., Eastern Time on February 25, 2013.

The financial results and live webcast will be accessible through the Investor
Relations section of the Company's Web site, www.impaxlabs.com.

To access the call through a conference line, dial (877) 356-3814 (in the
U.S.) and (706) 758-0033 (international callers). The conference ID is
90423980.

A replay of the conference call will be available for seven days shortly after
the call. To access the replay, dial (855) 859-2056 (in the U.S.) and (404)
537-3406 (international callers). The access code for the replay is 90423980.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. (NASDAQ: IPXL) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its generic
products through its Global Pharmaceuticals division and markets its branded
products through the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing partnerships to fully
leverage its technology platform. Impax Laboratories is headquartered in
Hayward, California, and has a full range of capabilities in its Hayward,
Philadelphia and Taiwan facilities. For more information, please visit the
Company's Web site at: www.impaxlabs.com.

Contact:

Impax Laboratories, Inc.
Mark Donohue
Sr. Director, Investor Relations and Corporate Communications
215-558-4526
www.impaxlabs.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement